Your browser doesn't support javascript.
loading
Corrigendum to "Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model." [Atherosclerosis 274 (July 2018) 120-127].
Nahon, Joya E; Hoekstra, Menno; Havik, Stefan R; Van Santbrink, Peter J; Dallinga-Thie, Geesje M; Kuivenhoven, Jan-Albert; Geerling, Janine J; Van Eck, Miranda.
Afiliação
  • Nahon JE; Division of BioTherapeutics, Leiden Academic Centre for Drug Research (LACDR), the Netherlands. Electronic address: j.e.nahon@lacdr.leidenuniv.nl.
  • Hoekstra M; Division of BioTherapeutics, Leiden Academic Centre for Drug Research (LACDR), the Netherlands.
  • Havik SR; Department of Experimental Vascular Medicine, Academic Medical Center Amsterdam, the Netherlands.
  • Van Santbrink PJ; Division of BioTherapeutics, Leiden Academic Centre for Drug Research (LACDR), the Netherlands.
  • Dallinga-Thie GM; Department of Experimental Vascular Medicine, Academic Medical Center Amsterdam, the Netherlands.
  • Kuivenhoven JA; Department of Pediatrics, University Medical Center Groningen, the Netherlands.
  • Geerling JJ; Division of BioTherapeutics, Leiden Academic Centre for Drug Research (LACDR), the Netherlands.
  • Van Eck M; Division of BioTherapeutics, Leiden Academic Centre for Drug Research (LACDR), the Netherlands.
Atherosclerosis ; 279: 132, 2018 Dec.
Article em En | MEDLINE | ID: mdl-30305237
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article